Genotypic and phenotypic spectrum of Myofibrillar Myopathy 7 as a result of Kyphoscoliosis Peptidase deficiency: The first description of a missense mutation in KY and literature review

Eur J Med Genet. 2022 Aug;65(8):104552. doi: 10.1016/j.ejmg.2022.104552. Epub 2022 Jun 22.

Abstract

KY is located on chromosome 3 and encodes a transglutaminase-like protein in the skeletal muscles, namely Kyphoscoliosis Peptidase. KY is primarily involved in the formation and stabilization of neuromuscular intersections making it essential for the development of the musculoskeletal system. Mutations in KY cause Myofibrillar Myopathy-7 (MFM-7) and Hereditary Spastic Paraplegia (HSP). MFM-7 is an early onset muscle disorder with an autosomal recessive inheritance marked by progressive muscle weakness and joint contractures. Herein, we describe an Iranian family with MFM-7 caused by a homozygous novel variant in KY. We identified a homozygous variant (NM_178554.6:c.1247T > A, p. Ile416Asn) in KY in two patients born to consanguineous parents and the same heterozygous mutation in their parent by Whole-Exome Sequencing. The patients manifest muscle weakness, muscle atrophy, mobility restriction, and hyporeflexia. Lastly, we reviewed the phenotype and corresponding genotype of the previously reported cases with pathogenic variants in KY.

Keywords: Hereditary spastic paraplegia; Kyphoscoliosis peptidase; Muscle weakness; Myofibrillar myopathies; Neuromuscular disorder.

Publication types

  • Review

MeSH terms

  • Homozygote
  • Humans
  • Iran
  • Muscle Weakness
  • Muscle, Skeletal / metabolism
  • Mutation
  • Mutation, Missense*
  • Myopathies, Structural, Congenital
  • Pedigree
  • Peptide Hydrolases / genetics
  • Phenotype
  • Spastic Paraplegia, Hereditary*

Substances

  • Peptide Hydrolases

Supplementary concepts

  • Myofibrillar Myopathy